KBI Biopharma Inc. sell "Selexis® SUREtechnology Platform™"
Basic Information
482
19
5
4.7(65)
Category
Subcategory & Sub-subcategory
Trade Type
Sell
Service Name
Selexis® SUREtechnology Platform™
Service Provider(s)
Specifications
- Expression System: Industry-proven, high-yield CHO-based mammalian cell line development platform
- Application: Accelerates biologics programs and overcomes expression challenges by delivering stable, scalable production for complex proteins
- Country of Origin: Switzerland; United States
Other Information
Additional Description:
The Selexis® SUREtechnology Platform™ is KBI Biopharma's proven solution for high-yield, high-quality CHO-based cell line development, built to accelerate biologics programs and overcome expression challenges with stable, scalable production even for complex proteins. It features the proprietary SURE CHO-M™ cell line optimized for strong, stable expression, transposase-enabled gene integration for precise, reproducible performance, and suitability for monoclonal antibodies, Fc-fusion proteins, bispecifics, and other novel biologics, with flexible packages spanning early discovery through late-stage development, drawing on decades of complex biologics experience to improve molecule developability from the start.
Ratings
(0)
(0)
(0)
(0)
(0)
Comments
Filters:
Sort by:
No comments available.
Matched Products & Services
B2B matches based on trade type, category, specifications & price range
Similar Products & Services
Products & Services related to what you're viewing
People Also Viewed
Other products & services viewed by people who looked at this product
Leave your rating & comment